NDUFB4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.289600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.981400E-01
Normal-vs-Stage2
5.360800E-01
Normal-vs-Stage3
8.521800E-01
Normal-vs-Stage4
5.648000E-01
Stage1-vs-Stage2
7.980200E-01
Stage1-vs-Stage3
9.397400E-01
Stage1-vs-Stage4
7.299200E-01
Stage2-vs-Stage3
7.526400E-01
Stage2-vs-Stage4
8.702800E-01
Stage3-vs-Stage4
7.831600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.807800E-01
Normal-vs-AfricanAmerican
8.062000E-01
Normal-vs-Asian
2.007400E-01
Caucasian-vs-AfricanAmerican
6.382600E-01
Caucasian-vs-Asian
3.638500E-02
AfricanAmerican-vs-Asian
1.010420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.901800E-01
Normal-vs-Female
4.688000E-01
Male-vs-Female
3.599400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.551200E-01
Normal-vs-Age(41-60Yrs)
3.418200E-01
Normal-vs-Age(61-80Yrs)
6.456800E-01
Normal-vs-Age(81-100Yrs)
2.954400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.485900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.485800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.905800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.365000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.764600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.382800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.709800E-01
Normal-vs-Daily Drinker
5.940400E-01
Normal-vs-Weekly Drinker
6.736400E-01
Normal-vs-Occasional Drinker
4.110000E-01
Normal-vs-Social Drinker
4.456200E-01
Non Drinker-vs-Daily Drinker
6.720600E-01
Non Drinker-vs-Weekly Drinker
9.131200E-01
Non Drinker-vs-Occasional Drinker
1.616410E-01
Non Drinker-vs-Social Drinker
2.459200E-01
Daily Drinker-vs-Weekly Drinker
7.740200E-01
Daily Drinker-vs-Occasional Drinker
2.941000E-01
Daily Drinker-vs-Social Drinker
4.028200E-01
Weekly Drinker-vs-Occasional Drinker
2.279000E-01
Weekly Drinker-vs-Social Drinker
3.307200E-01
Occasional Drinker-vs-Social Drinker
8.642000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.892150E-01
Normal-vs-Grade 2
2.800200E-02
Normal-vs-Grade 3
4.120100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.389360E-01
Grade 1-vs-Grade 3
8.026400E-02
Grade 1-vs-Grade 4
1.892150E-01
Grade 2-vs-Grade 3
3.867800E-01
Grade 2-vs-Grade 4
2.800200E-02
Grade 3-vs-Grade 4
4.120100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.048800E-01
Normal-vs-NonDiabetic
4.224800E-01
Diabetic-vs-NonDiabetic
2.550000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.210400E-02
Normal-vs-NoPancreatitis
5.991000E-01
Pancreatitis-vs-NoPancreatitis
1.012390E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.648400E-01
Normal-vs-N1
5.624200E-01
N0-vs-N1
5.503600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.088020E-01
Normal-vs-TP53-NonMutant
9.100200E-01
TP53-Mutant-vs-TP53-NonMutant
1.85389999995955E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
